Share
Journal Information
Issue
Vol. 41. Issue 1.Pages 1-102 (January - March 2019)
Original articles
Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study
José Alfreu Soares Júnior, Glaucia Helena Martinho, Antonio Vaz de Macedo, Marisa Ribeiro Verçosa, Vandack Nobre, Gustavo Machado Teixeira
Hematol Transfus Cell Ther. 2019;41:1-6
Open access
Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue
Tanya Debnath, Lakshmi Kiran Chelluri
Hematol Transfus Cell Ther. 2019;41:7-16
Open access
Role of physical function in predicting short-term treatment outcome in Egyptian acute myeloid leukemia patients: a single center experience
Mohamed A. Fateen, Doaa M. El Demerdash, Rania A. Zayed, Mervat M. Mattar
Hematol Transfus Cell Ther. 2019;41:17-24
Open access
Genotyping of Dombrock and Lutheran blood group systems in blood donors from the southwestern region of the state of Paraná, Southern Brazil
Ieda Bernadete Volkweis Langer, Jeane Eliete Laguila Visentainer, Joana Maira Valentini Zacarias, Katia Teixeira de Meiroz Grilo, Paulo Roberto Hatschbach, Rosane Scotti Zimmermann, Ana Maria Sell
Hematol Transfus Cell Ther. 2019;41:25-30
Open access
Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus – a study at a tertiary care center in Delhi
Charu Agarwal, Kashish Bansal, Mukta Pujani, Kanika Singh, Varsha Chauhan, Deepshikha Rana, Shveta Lukhmana
Hematol Transfus Cell Ther. 2019;41:31-6
Open access
Assessment of the knowledge and perceptions of Brazilian medical residents on transfusion medicine
Marcella Martins de Vasconcelos Vaena, Luiz Anastacio Alves
Hematol Transfus Cell Ther. 2019;41:37-43
Open access
Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping
Marília Gonçalves Quirino, Cristiane Maria Colli, Luciana Conci Macedo, Ana Maria Sell, Jeane Eliete Laguila Visentainer
Hematol Transfus Cell Ther. 2019;41:44-9
Open access
Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma
Laura Fogliatto, Kamila Castro Grokoski, Yuri Machado Strey, Tito Vanelli, Christina Garcia da Silva Fraga, Marines Bizarro Barra, Fernanda Correa Pinto, Israel Bendit, Claúdia Giuliano Bica
Hematol Transfus Cell Ther. 2019;41:50-6
Open access
Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center
José Carlos Jaime-Pérez, Gisela García-Arellano, José Luis Herrera-Garza, Luis Javier Marfil-Rivera, David Gómez-Almaguer
Hematol Transfus Cell Ther. 2019;41:57-61
Open access
Knowledge of professional healthcare providers about sickle cell disease: Impact of a distance education course
Katy Karoline Santos Diniz, Adriana Silvina Pagano, Ana Paula Pinheiro Chagas Fernandes, Ilka Afonso Reis, Leonardo Gonçalves Pinheiro Júnior, Heloísa de Carvalho Torres
Hematol Transfus Cell Ther. 2019;41:62-8
Open access
Review articles
Female genital tract chronic graft-versus-host disease: A narrative review
Andréa Maria Novaes Machado, Nelson Hamerschlak, Morgani Rodrigues, Carla de Azevedo Piccinato, Sergio Podgaec, Lenira Maria Queiroz Mauad
Hematol Transfus Cell Ther. 2019;41:69-75
Open access
New proteasome inhibitors in the treatment of multiple myeloma
Vania Tietsche de Moraes Hungria, Edvan de Queiroz Crusoé, Rosane Isabel Bittencourt, Angelo Maiolino, Roberto José Pessoa Magalhães, Jairo do Nascimento Sobrinho, Jorge Vaz Pinto, Ricardo Coutinho Fortes, ... Paula Yurie Tanaka
Hematol Transfus Cell Ther. 2019;41:76-83
Open access
Case reports
Minimally differentiated acute myeloid leukemia with ring/marker derived from chromosome 7 in a child with Down syndrome
Maria Luiza Rocha da Rosa Borges, Eliane Maria Soares-Ventura, Thomas Liehr, Terezinha de Jesus Marques-Salles
Hematol Transfus Cell Ther. 2019;41:84-7
Open access
Current role of interferon in hairy cell leukemia therapy: a timely decision
Wellington Fernandes da Silva, Larissa Lane Cardoso Teixeira, Vanderson Rocha, Valeria Buccheri
Hematol Transfus Cell Ther. 2019;41:88-90
Open access
Role of conventional cytogenetics in sequential karyotype analysis of myelodysplastic syndrome: a patient with der(1;7)(q10;p10)
Ivo Gabriel da Frota França, Mayara Magna Lima de Melo, Manuela Soares Couto Teixeira, Joao Victor Alves Cordeiro, Daniela de Paula Borges, Roberta Taiane Germano de Oliveira, Silvio Rocha Furtado, Silvia Maria Meira Magalhães, Ronald Feitosa Pinheiro
Hematol Transfus Cell Ther. 2019;41:91-4
Open access
Atypical herpes vasculitis in a leukemic patient: An unusual presentation
Jade Cury-Martins, Marcelo Bellesso, Mirian Nacagami Sotto, Jose Antonio Sanches
Hematol Transfus Cell Ther. 2019;41:95-8
Open access
Image in clinical hematology
Visceral leishmaniasis: amastigotes in the bone marrow
Thiago Rodrigo de Noronha, Ricardo Ambrósio Fock
Hematol Transfus Cell Ther. 2019;41:99-100
Open access
Letter to the editor
Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
Gil Cunha De Santis, Benedito de Pina Almeida Prado, Giuliana Martinelli Dotoli, Belinda Pinto Simões, Dimas Tadeu Covas
Hematol Transfus Cell Ther. 2019;41:101-2
Open access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.